BREvipil Oral Solution

Description

BREvipil Oral Solution is a prescription medicine manufactured by Sun Pharmaceutical Industries Ltd. It contains Brivaracetam (10mg per 5ml), an antiepileptic drug that works by modulating neurotransmitter activity in the brain to prevent and control seizure episodes.

This liquid formulation is ideal for patients who cannot swallow tablets or require precise dose adjustment, including children and elderly patients.

Uses

• Management of partial-onset seizures in epilepsy

• Reduces the frequency and severity of seizure episodes

• Suitable for patients unable to take tablets

• Can be used alone or as adjunct therapy with other antiepileptic drugs

Dosage

• Take as prescribed by your doctor

• Use a proper measuring device (spoon or syringe) for accurate dosing

• Can be taken once or twice daily depending on the prescription

• Shake well before each use

Side Effects

• Drowsiness, dizziness, or fatigue

• Nausea or vomiting

• Irritability or mood changes

• Rare: severe allergic reactions

Precautions

• Inform your doctor if you have a history of depression, suicidal thoughts, or liver/kidney issues

• Not recommended during pregnancy or breastfeeding unless prescribed

• Avoid abrupt discontinuation to prevent seizure recurrence

• Limit alcohol consumption while on this medication

Storage

• Store in a cool, dry place, away from sunlight

• Keep out of reach of children

• Do not use if the solution appears discolored or contains particles